G1 Therapeutics (GTHX) stock forecast for 2026. Forecast tables and graphs.







Where to Rent Stable Turkish Datacenter Proxies?

July 1, 2025 Where to Rent Stable Turkish Datacenter Proxies?

In a digital landscape where online anonymity and efficiency are essential, datacenter proxies have become a fundamental tool for businesses, SEO specialists, and…
PayPal’s News Analysis—A Short and Medium-Term Price Forecast

June 24, 2025 PayPal’s News Analysis—A Short and Medium-Term Price Forecast

This analytical article cuts through the noise, offering a focused forecast for PYPL’s stock price movement in both the short (5 days) and…
Understanding Accounting and Bookkeeping Services for Business Success

June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success

Every successful business relies on accurate financial records. From managing cash flow to ensuring compliance with tax regulations, reliable accounting and bookkeeping services…
How much does a Turkish passport cost?

May 27, 2025 How much does a Turkish passport cost?

Turkish citizenship comes with numerous benefits. Once granted, a foreigner can enter 126 countries visa-free, enjoy high-quality healthcare and favorable tax regimes, and…
How Measurement and Mix Modeling Drive Better Business Decisions

May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions

In today’s data-driven business landscape, the ability to accurately measure and optimize marketing efforts has become a critical competitive advantage. As marketing evolves,…

G1 Therapeutics (GTHX) stock forecast for 2026

Updated: May 31, 2025 (04:02)

Sector: Healthcare

The share price of G1 Therapeutics, Inc. (GTHX) now

This company is DELISTED
What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For G1 Therapeutics stocks, the 50-day moving average is the support level today.

For G1 Therapeutics stocks, the 200-day moving average is the support level today.

Are you interested in G1 Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the G1 Therapeutics stock price in 2026. How much will one G1 Therapeutics share be worth in 2026? Is it worth taking profit / loss on GTHX stock now or waiting? What are analysts' forecasts for G1 Therapeutics stock?

We forecast G1 Therapeutics stock performance using neural networks based on historical data on GTHX stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

G1 Therapeutics, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for G1 Therapeutics analysts is $. Today 200 Day Moving Average is the support level ( $). 50 Day Moving Average is the support level ( $).




Historical and forecast chart of G1 Therapeutics, Inc. stock

The chart below shows the historical price of G1 Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the GTHX stock price can be found in the table below.

No data

G1 Therapeutics, Inc. is a clinical biopharmaceutical company that develops and delivers innovative treatments that improve the lives of people with cancer.

Official site of the company

Trending Themes in the Healthcare Sector

G1 Therapeutics (GTHX) Forecast for 2026

Month Target Pes. Opt. Vol., %
Jan 5.89 5.43 7.06 23.18 %
Mar 5.70 4.77 6.63 28.05 %
Mar 6.94 6.38 8.27 22.88 %
May 7.56 6.89 8.99 23.39 %
May 8.01 6.58 9.52 30.88 %
Jul 8.23 6.54 9.82 33.46 %
Jul 8.87 7.43 9.54 22.09 %
Aug 10.45 9.27 11.13 16.74 %
Oct 9.91 7.88 10.69 26.29 %
Oct 9.94 7.87 10.48 24.85 %
Dec 12.33 11.30 14.53 22.23 %
Dec 12.03 9.66 13.85 30.26 %

G1 Therapeutics information and performance

G1 Therapeutics Address

N/A

Market Capitalization: N/A $

Market capitalization of the G1 Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GTHX shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of G1 Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

G1 Therapeutics price target for 2026 by month


Target values for the price of one G1 Therapeutics share for Jan 2026.

The weighted average target price per G1 Therapeutics share in Jan 2026 is: 5.89.
In Jan, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 23.179% volatility is expected.
Pessimistic target level: 5.43
Optimistic target level: 7.06

Target values for the price of one G1 Therapeutics share for Mar 2026.

The weighted average target price per G1 Therapeutics share in Mar 2026 is: 5.70.
In Mar, the Negative dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 28.050% volatility is expected.
Pessimistic target level: 4.77
Optimistic target level: 6.63

Target values for the price of one G1 Therapeutics share for Mar 2026.

The weighted average target price per G1 Therapeutics share in Mar 2026 is: 6.94.
In Mar, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 22.883% volatility is expected.
Pessimistic target level: 6.38
Optimistic target level: 8.27

Target values for the price of one G1 Therapeutics share for May 2026.

The weighted average target price per G1 Therapeutics share in May 2026 is: 7.56.
In May, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 23.389% volatility is expected.
Pessimistic target level: 6.89
Optimistic target level: 8.99

Target values for the price of one G1 Therapeutics share for May 2026.

The weighted average target price per G1 Therapeutics share in May 2026 is: 8.01.
In May, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 30.883% volatility is expected.
Pessimistic target level: 6.58
Optimistic target level: 9.52

Target values for the price of one G1 Therapeutics share for Jul 2026.

The weighted average target price per G1 Therapeutics share in Jul 2026 is: 8.23.
In Jul, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 33.456% volatility is expected.
Pessimistic target level: 6.54
Optimistic target level: 9.82

Target values for the price of one G1 Therapeutics share for Jul 2026.

The weighted average target price per G1 Therapeutics share in Jul 2026 is: 8.87.
In Jul, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 22.090% volatility is expected.
Pessimistic target level: 7.43
Optimistic target level: 9.54

Target values for the price of one G1 Therapeutics share for Aug 2026.

The weighted average target price per G1 Therapeutics share in Aug 2026 is: 10.45.
In Aug, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 16.736% volatility is expected.
Pessimistic target level: 9.27
Optimistic target level: 11.13

Target values for the price of one G1 Therapeutics share for Oct 2026.

The weighted average target price per G1 Therapeutics share in Oct 2026 is: 9.91.
In Oct, the Negative dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 26.291% volatility is expected.
Pessimistic target level: 7.88
Optimistic target level: 10.69

Target values for the price of one G1 Therapeutics share for Oct 2026.

The weighted average target price per G1 Therapeutics share in Oct 2026 is: 9.94.
In Oct, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 24.848% volatility is expected.
Pessimistic target level: 7.87
Optimistic target level: 10.48

Target values for the price of one G1 Therapeutics share for Dec 2026.

The weighted average target price per G1 Therapeutics share in Dec 2026 is: 12.33.
In Dec, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 22.229% volatility is expected.
Pessimistic target level: 11.30
Optimistic target level: 14.53

Target values for the price of one G1 Therapeutics share for Dec 2026.

The weighted average target price per G1 Therapeutics share in Dec 2026 is: 12.03.
In Dec, the Negative dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 30.255% volatility is expected.
Pessimistic target level: 9.66
Optimistic target level: 13.85



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.